IDiyas

For the Inventor, By the Inventor

Cambridge, MA, United States of America

Steven James Ferrara

USPTO Granted Patents = 17 

 

Average Co-Inventor Count = 19.8

ph-index = 3

Forward Citations = 36(Granted Patents)


Company Filing History:

goldMedal16 out of 443 
 
The Broad Institute, Inc.
 patents
silverMedal15 out of 12,157 
 
Bayer Aktiengesellschaft
 patents
bronzeMedal12 out of 378 
 
Bayer Pharma Aktiengesellschaft
 patents
4. 6 out of 2,961 
 
Harvard College
 patents
5. 6 out of 2,882 
 
The General Hospital Corporation
 patents
6. 1 out of 1 
 
Bayer Pharma Aktiengellschaft
 patent
7. 1 out of 5 
 
Bayer Aktiengellschaft
 patents
8. 1 out of 1 
 
Bayer Pharma Aktiegellschaft
 patent
9. 1 out of 832,680 
Other
 patents
where one patent can have more than one assignee

Years Active: 2020-2025

Loading Chart...
Loading Chart...
17 patents (USPTO):
1. 12486248 - 2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH (2025-12-02),
2. 12357603 - Acyl sulfonamides for treating cancer (2025-07-15),
3. 12338250 - Methods of preparing macrocyclic indoles (2025-06-24),
4. 12152041 - Macrocyclic fluorine substituted indole derivatives (2024-11-26),
5. 11891404 - Substituted macrocyclic indole derivatives (2024-02-06),
6. 11787797 - 4,5-annulated 1,2,4-triazolones (2023-10-17),
7. 11713304 - 2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH (2023-08-01),
8. 11492358 - Macrocyclic indole derivatives (2022-11-08),
9. 11478451 - Macrocyclic chlorine substituted indole derivatives (2022-10-25),
10. 11447504 - Macrocyclic chlorine substituted indole derivatives (2022-09-20),
11. 11440923 - Substituted macrocyclic indole derivatives (2022-09-13),
12. 11401278 - Macrocyclic indole derivatives (2022-08-02),
13. 11286263 - Macrocyclic fluorine substituted indole derivatives (2022-03-29),
14. 11130745 - 2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH (2021-09-28),
15. 10981932 - Macrocyclic indole derivatives (2021-04-20),

Title: The Innovative Contributions of Steven James Ferrara

Introduction

Steven James Ferrara is a prominent inventor based in Cambridge, MA, known for his significant contributions to the field of pharmaceuticals. With a total of 16 patents to his name, Ferrara has made remarkable strides in developing compounds that address critical health issues, particularly in cancer treatment.

Latest Patents

Among his latest patents, Ferrara has developed acyl sulfonamide compounds aimed at treating cancer. This invention provides acyl sulfonamide compounds of general formula (I), which are essential for creating pharmaceutical compositions for the treatment or prophylaxis of diseases, especially hyperproliferative disorders. Additionally, he has worked on methods for preparing macrocyclic indoles, which relate to substituted indole derivatives of general formula (I). These methods include intermediate compounds that are useful for synthesizing the aforementioned compounds.

Career Highlights

Ferrara has had a distinguished career, working with notable organizations such as the Broad Institute, Inc. and Bayer Aktiengesellschaft. His work in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Throughout his career, Ferrara has collaborated with esteemed colleagues, including Kai Thede and David A McKinney. These partnerships have further enhanced his research and innovation capabilities.

Conclusion

Steven James Ferrara's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a key inventor in the industry. His work continues to pave the way for advancements in cancer treatment and other medical applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…